Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer

Australasian Physical and Engineering Sciences in Medicine

Volumn 30, Issue 3, 2007, Pages 178-184

  Das, R ^a   Toye, W ^b,c   Kron, Tomas ^a,b   Williams, S ^a   Duchesne, G ^a,d  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b RMIT UNIVERSITY   (Australia)

^c Radiation Oncology Victoria   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

HDR brachytherapy; In vivo dosimetry; Prostate cancer; Rectum dose; TLD; Treatment planning; Urethra dose

Indexed keywords

DOSIMETRY; DRUG DELIVERY; DRUG DOSAGE; THERMOLUMINESCENCE;

HIGH DOSE RATE BRACHYTHERAPY BOOST; LORENTZIAN PEAK FUNCTION; PROSTATE CANCER; RECTUM DOSE; THERMOLUMINESCENCE DOSIMETRY; URETHRA DOSE;

ONCOLOGY;

ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IN VIVO STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DETECTOR; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RECTUM INJURY; THERMOLUMINESCENCE DOSIMETRY; TREATMENT PLANNING; URETHRA INJURY;

EID: 35349000002     PISSN: 01589938     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03178424     Document Type: Article

References (24)

1. Martinez, A.A., Pataki, I., Edmundson, G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a.feasibility report. Int J Radiat Oncol Biol Phys 49: 61-69, 2001.
2. Morton, G.C. The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol) 17: 219-227, 2005.
3. Khoo, V.S., Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy. Clin Oncol (R Coll Radiol) 17: 560-571, 2005.
4. Chin, Y.S., Bullard, J., Bryant, L., et al., High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. Clin Oncol (R Coll Radiol) 18: 474-479, 2006.
5. Pinkawa, M., Fischedick, K., Treusacher, P., et al., Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer - a phase II study. Radiother Oncol 78: 41-46, 2006.
6. Duchesne, G.M. and Peters, L.J., What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 44: 747-748, 1999.
7. Fowler, J.F., The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44: 265-276, 2005.
8. Yoshioka, Y., Nose, T., Yoshida, K., et al., High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 56: 213-220, 2003.
9. Grills, I.S., Martinez, A.A., Hollander, M., et al., High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171: 1098-1104, 2004.
10. Hoskin, P.J., Bownes, P.J., Ostler, P., et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 68: 285-288, 2003.
11. Mullokandov, E. and Gejerman, G., Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 58: 1063-1071, 2004.
12. Brezovich, I.A., Duan, J., Pareek, P.N., et al., In vivo urethral dose measurements: a method to verify high dose rate prostate treatments. Med Phys 27: 2297-2301, 2000.
13. Hood, C., Duggan, L., Bazley, S., et al., LiF:Mg, Cu, P 'pin worms': miniature detectors for brachytherapy dosimetry. Radiat Prot Dosimetry 101: 407-410, 2002.
14. Anagnostopoulos, G., Baltas, D., Geretschlaeger, A., et al., In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 57: 1183-1191, 2003.
15. Ghilezan, M., Jaffray, D., Siewerdsen, J., et al., Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 62: 406-417, 2005.
16. Feist, H., Influence of regenerating and evaluation procedures on the supralinear behavior of LiF thermoluminescent dosimeters. Strahlenther.Onkol 164: 223-227, 1988 (in German).
17. Waldhausl, C., Wambersie, A., Potter, R. and Georg, D., In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations. Radiother Oncol 77: 310-317, 2005.
18. Kron, T., Duggan, L., Smith, T., et al., Dose response of various radiation detectors to synchrotron radiation. Phys.Med.Biol 43: 3235-3259, 1998.
19. Duggan, L., Hood, C., Warren-Forward, H., et al., Variations in dose response with x-ray energy of LiF:Mg, Cu, P thermoluminescence dosimeters: implications for clinical dosimetry. Phys.Med.Biol 49:3831-3845, 2004.
20. Kron, T., Thermoluminescence dosimetry and its applications in medicine - Part 1: Physics, materials and equipment. Australas Phys Eng Sci Med 17: 175-199, 1994.
21. Lee, W.R., deGuzman, A.F., Bare, R.L., et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46: 83-88, 2000.
22. Keyes, M., Schellenberg, D., Moravan, V., et al., Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve? Int J Radiat Oncol Biol Phys 64: 825-834, 2006.
23. Kapp, K.S., Stuecklschweiger, G.F., Kapp, D.S. and Hackl, A.G. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol 24: 137-146, 1992.
24. Alecu, R., and Alecu, M., In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix. Med Phys 26: 768-770, 1999.